<DOC>
	<DOCNO>NCT01223820</DOCNO>
	<brief_summary>The term idiopathic rhinitis ( IR ) use study describe patient group follow characteristic : patient complaint nasal obstruction , sneeze and/or rhinorrhea period 1 year , attribute allergy , nasal paranasal infection , anatomical disorder , pregnancy lactation and/or systemic disorder . These patient non-smokers use medication affect nasal function . They beneficial effect intranasal steroid spray ( INS ) treatment . The population incidence IR estimate high 10 % . The pathophysiology IR largely unknown . Several hypothesis put forward . In general assume neurogenic mechanism play important role . Neuropeptides like CGRP , SP , NKA/B , NPY , NGF release afferent neuron nasal mucosa activation unspecific stimulus responsible symptom IR . For group IR-patients , one treatment option : intranasal capsaicin application . Capsaicin , pungent agent hot pepper , suppose exert ' therapeutic effect via degeneration desensitization effect afferent C-fibers . The hypothesis nasal capsaicin treatment reduce neurogenic inflammation reduces way nasal symptom .</brief_summary>
	<brief_title>Neuro-immunological Analysis Idiopathic Rhinitis Patients Controls Treated With Capsaicin .</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>1 . Patients persistent ( &gt; 12w ) rhinological symptom : nasal discharge , sneeze , congestion average least 1 h per day least 5 day period 14 day , negative skin prick test negative RAST , without structural abnormality explain nasal obstruction propose participate trial . 2 . Age &gt; 18 &lt; 50 year 3 . Written inform consent 4 . Willingness adhere visit schedule 5 . Adequate contraceptive precaution female patient childbearing potential 6 . Unresponsiveness nasal steroid spray ( 4 week use ) 1 . Age &lt; 18 &gt; 50 year 2 . Patients AR , demonstrate either positive skin prick test RAST 3 . Presence IgE nasal lavage fluid 4 . Structural abnormality : nasal polyp , severe septal deviation ( septum reach concha inferior lateral nasal wall . 5 . Systemic steroid treatment le 4 week inclusion study . 6 . Nasal steroid spray le 4 week inclusion , oral leukotriene antagonist longacting antihistamine less 2 week inclusion . 7 . Inability patient stop take medication affect nasal function . 8 . Evidence infectious rhinitis/rhinosinusitis . 9 . Pregnancy breastfeed . 10 . Any disorder might compromise ability patient give truly informed consent participation study . 11 . Enrollment investigational drug trial ( ) receive investigational agent ( ) medical condition . 12 . Contraindications local anaesthesia ( Coca√Øne 5 % ) . 13 . Smoking . 14 . Systemic disease lesion ENT domain . 15 . Malignancies severe comorbidity .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>